Literature DB >> 22584542

Ophthalmic features of optic disc drusen.

Patricia Flores-Rodríguez1, Pablo Gili, María Dolores Martín-Ríos.   

Abstract

PURPOSE: To evaluate the ophthalmoscopic manifestations of patients with visible and hidden optic disc drusen (ODD).
METHOD: We studied 55 patients (100 eyes) with ODD that were confirmed using B-scan ultrasonography and a control group of 60 patients (100 eyes) for differential diagnosis. We analysed the optic nerve features with stereoscopic photography and compared the characteristics between visible and hidden ODD and between hidden ODD and papilloedema.
RESULTS: The patients with ODD presented the following ophthalmoscopic features: visible drusen (52%), blurred edges (84%), raised optic disc (74%), absence of optic disc cupping (69%), absence of venous pulse (54%), abnormal vascular branching (81%), presence of cilioretinal vessels (42%), peripapillary atrophy (56%) and haemorrhages (2%). Comparison of the qualitative characteristics of the papillae of the eyes with visible and hidden ODD showed statistically significant differences in all parameters studied, except for morphological alterations (p = 0.851) and haemorrhage (p = 0.954). Comparison of hidden ODD with papilloedema showed statistically significant differences in blurred edges, disc elevation, absence of optic disc cupping, altered colour, anomalous vascular branching and optic disc haemorrhages (p < 0.005).
CONCLUSIONS: Ophthalmologic features associated with ODD can help us to diagnose their presence and avoid confusing them with papilloedema.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22584542     DOI: 10.1159/000337842

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  9 in total

Review 1.  Optic Nerve Head Drusen: An Update.

Authors:  Edward Palmer; Jesse Gale; Jonathan G Crowston; Anthony P Wells
Journal:  Neuroophthalmology       Date:  2018-04-25

2.  A single injection of intravitreal ranibizumab in the treatment of choroidal neovascularisation secondary to optic nerve head drusen in a child.

Authors:  Zeynep Alkin; Abdullah Ozkaya; Ihsan Yilmaz; Ahmet Taylan Yazici
Journal:  BMJ Case Rep       Date:  2014-05-02

3.  Sensitivity and specificity of monochromatic photography of the ocular fundus in differentiating optic nerve head drusen and optic disc oedema: optic disc drusen and oedema.

Authors:  Pablo Gili; Patricia Flores-Rodríguez; Julio Yangüela; Javier Orduña-Azcona; María Dolores Martín-Ríos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-05       Impact factor: 3.117

Review 4.  Optic disk drusen in children.

Authors:  Melinda Y Chang; Stacy L Pineles
Journal:  Surv Ophthalmol       Date:  2016-03-29       Impact factor: 6.048

5.  The effect of parental factors in children with large cup-to-disc ratios.

Authors:  Hae-Young Lopilly Park; Min Ji Ha; Sun Young Shin
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

6.  Unilateral optic disc drusen mis-diagnosed as optic neuritis: Diagnostic and therapeutic implications.

Authors:  Georgios Bontzos; Georgios Smoustopoulos; Theocharis Efstathios Detorakis
Journal:  Rom J Ophthalmol       Date:  2020 Oct-Dec

Review 7.  Literature Review on Artificial Intelligence Methods for Glaucoma Screening, Segmentation, and Classification.

Authors:  José Camara; Alexandre Neto; Ivan Miguel Pires; María Vanessa Villasana; Eftim Zdravevski; António Cunha
Journal:  J Imaging       Date:  2022-01-20

8.  Unilateral Acute Anterior Ischemic Optic Neuropathy in a Patient with an Already Established Diagnosis of Bilateral Optic Disc Drusen.

Authors:  Ziya Ayhan; Aylin Yaman; Meltem Söylev Bajin; A Osman Saatci
Journal:  Case Rep Ophthalmol Med       Date:  2015-10-15

9.  Detection of Optic Disc Drusen in Children Using Ultrasound through the Lens and Avoiding the Lens-Point of Care Ultrasound Technique of Evaluation Revisited.

Authors:  Renuka Rajagopal; Ellen Mitchell; Christin Sylvester; Lea Ann Lope; Ken Kanwal Nischal
Journal:  J Clin Med       Date:  2019-09-12       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.